Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses

Author:

Yang Xuan12,Dickmander Rebekah J.2345,Bayati Armin6,Taft-Benz Sharon A.27,Smith Jeffery L.1,Wells Carrow I.1ORCID,Madden Emily A.7,Brown Jason W.8,Lenarcic Erik M.234,Yount Boyd L.9,Chang Edcon8,Axtman Alison D.12ORCID,Baric Ralph S.29,Heise Mark T.27,McPherson Peter S.6,Moorman Nathaniel J.234,Willson Timothy M.12ORCID

Affiliation:

1. Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

2. Rapidly Emerging Antiviral Drug Development Initiative (READDI), Chapel Hill, North Carolina 27599, United States

3. Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

5. Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

6. Structural Genomics Consortium, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada

7. Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

8. Takeda San Diego, San Diego, California 92121, United States

9. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

North Carolina General Assembly

Parkinson Society Canada

Takeda Pharmaceutical Company

Fonds de recherche du Québec

North Carolina Biotechnology Center

U.S. Department of Defense

Graduate School, University of North Carolina at Chapel Hill

Natural Sciences and Engineering Research Council of Canada

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3